USA - NYSE:CAH - US14149Y1082 - Common Stock
The current stock price of CAH is 203.67 USD. In the past month the price increased by 29.83%. In the past year, price increased by 68.94%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| MCK | MCKESSON CORP | 23.49 | 105.97B | ||
| COR | CENCORA INC | 22.56 | 69.93B | ||
| HSIC | HENRY SCHEIN INC | 14.92 | 8.72B | ||
| AHCO | ADAPTHEALTH CORP | 29.69 | 1.29B | ||
| OMI | OWENS & MINOR INC | 2.47 | 245.62M | ||
| WGRX | WELLGISTICS HEALTH INC | N/A | 58.41M |
Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. The company is headquartered in Dublin Ohio, Ohio and currently employs 57,700 full-time employees. The firm is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The firm also provides pharmaceuticals and medical products. The Company’s segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The firm connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.
CARDINAL HEALTH INC
7000 Cardinal Pl
Dublin Ohio OHIO 43017 US
CEO: Michael C. Kaufmann
Employees: 57700
Phone: 16147573033
Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. The company is headquartered in Dublin Ohio, Ohio and currently employs 57,700 full-time employees. The firm is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The firm also provides pharmaceuticals and medical products. The Company’s segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The firm connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.
The current stock price of CAH is 203.67 USD. The price increased by 2.87% in the last trading session.
CARDINAL HEALTH INC (CAH) has a dividend yield of 1.03%. The yearly dividend amount is currently 2.05.
CAH has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
The Revenue of CARDINAL HEALTH INC (CAH) is expected to grow by 13.75% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
CARDINAL HEALTH INC (CAH) has a market capitalization of 48.39B USD. This makes CAH a Large Cap stock.
CARDINAL HEALTH INC (CAH) will report earnings on 2026-01-28, before the market open.
ChartMill assigns a technical rating of 10 / 10 to CAH. When comparing the yearly performance of all stocks, CAH is one of the better performing stocks in the market, outperforming 92.87% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to CAH. CAH has an average financial health and profitability rating.
Over the last trailing twelve months CAH reported a non-GAAP Earnings per Share(EPS) of 8.91. The EPS increased by 16.93% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.68% | ||
| ROA | 2.89% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
22 analysts have analysed CAH and the average price target is 185.28 USD. This implies a price decrease of -9.03% is expected in the next year compared to the current price of 203.67.
For the next year, analysts expect an EPS growth of 18% and a revenue growth 13.75% for CAH